Because BTK is expressed in B cells and macrophages, and their crosstalk results in polarization of macrophages to a M2-like tumor-promoting endotype, Ibrutinib treatment of a mouse PDAC model restored T cell-dependent anti-tumor responses and enhanced sensitivity to standard of care gemcitabine [135]. This evidence concerns the gene BTK and neoplasm.